PubMed Health treatment related to Hyperthyroidism: 63
Mild hyperthyroidism sometimes gets better on its own, without treatment . But the overproduction of thyroid hormones is usually first stopped using tablets called anti-thyroid drugs. In Graves disease , long-term treatment with this medication can make the thyroid function return to normal. If that doesn’t happen, the thyroid gland is surgically removed or treated with radioactive iodine . Known as radioiodine therapy , this involves swallowing radioactive iodine which is then absorbed by your thyroid gland, where it destroys overactive cells . If the overactive thyroid is caused by an enlarged thyroid gland with “autonomous” cells , the thyroid gland that has been “slowed down” with anti-thyroid drugs is usually surgically removed. If surgery isn’t possible or the thyroid gland isn’t greatly enlarged, radioiodine therapy tends to be more suitable.
Drugs for Hyperthyroidism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 98)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Β-propranolol
|
|
2 |
|
Lithium carbonate |
Approved |
Phase 4 |
|
554-13-2 |
|
Synonyms:
CAMCOLIT 250
CAMCOLIT 400
Carbonic acid, dilithium salt
CP-1546761
CP-15467-61
Dilithium carbonate
ESKALITH
ESKALITH CR
LISKONUM
|
LITHANE
Lithii carbonas
LITHIUM CARBONATE
LITHOBID
LITHONATE
LITHOTABS
NSC-16895
PHASAL
|
|
3 |
|
Iodine |
Approved, Investigational |
Phase 4 |
|
7553-56-2 |
807 |
Synonyms:
Cadex
Diiodine
I2
Iode
Iodine
Iodine 127
Iodine-127
Iodine-molecule
|
Iodio
iodo
Iodum
Jod
Jood
Molecular iodine
NSC-42355
Tincture iodine
|
|
4 |
|
Cadexomer iodine |
Experimental |
Phase 4 |
|
94820-09-4 |
|
Synonyms:
|
5 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
6 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
7 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
8 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
9 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
10 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
11 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
12 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
13 |
|
Lugol's solution |
|
Phase 4 |
|
|
|
14 |
|
Propylthiouracil |
Approved, Investigational |
Phase 3 |
|
51-52-5 |
657298 |
Synonyms:
2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone
2-Mercapto-6-propyl-4-pyrimidone
2-Mercapto-6-propylpyrimid-4-one
2-Thio-4-oxo-6-propyl-1,3-pyrimidine
2-Thio-6-propyl-1,3-pyrimidin-4-one
4-Propyl-2-thiouracil
6 Propyl 2 thiouracil
6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione
6-Propyl-2-thiouracil
6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one
6-Propylthiouracil
6-Thio-4-propyluracil
NSC-6498
NSC-70461
Procasil
Propacil
Propilthiouracil
Propiltiouracilo
Propycil
|
Propyl-thiorist
Propylthiorit
Propyl-thiorit
Propylthiouracil
Propylthiouracile
Propylthiouracilum
Propyl-thyracil
Propythiouracil
Prothiucil
Prothiurone
Prothycil
Prothyran
Protiural
PTU
Thiuragyl
THYREOSTAT
Thyreostat II
Thyreostat®
|
|
15 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 3 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
16 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 3 |
|
52-21-1 |
|
Synonyms:
ECONOPRED
FLO-PRED
METICORTELONE
NSC-10966
OMNIPRED
PRED FORTE
|
PRED FTE
PRED MILD
PREDNISOLONE 21-ACETATE
PREDNISOLONE ACETATE
STERANE
ULTRACORTENOL
|
|
17 |
|
Prednisolone |
Approved, Vet_approved |
Phase 3 |
|
50-24-8 |
4894 5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11Β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
3,20-Dioxo-11b,17a,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Codelcortone
Co-Hydeltra
Cordrol
CORTALONE
Cotogesic
Cotolone
Decaprednil
Decortin H
DEKOTIL
Delcortol
Delta F
Delta(1)-Dehydrocortisol
Delta(1)-Dehydrohydrocortisone
Delta(1)-Hydrocortisone
DELTA.1-CORTISOL
DELTA.1-Cortisol|Orapred®|Pediapred®
Delta-Cortef
Deltacortenol
DELTACORTRIL
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
Deltahydrocortisone
DELTALONE
Deltasolone
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
DESOWEN
Dexa-Cortidelt Hostacortin H
Di adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Dicortol
DILACORT
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
FERNISOLONE-P
Flamasone
Hostacortin H
HYDELTRA
Hydeltrasol
HYDELTRA-TBA
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
IMS904
Inflamase Forte
Inflamase Mild
I-Pred
Key-Pred
Klismacort
Lentosone
Lite Pred
Medrol
|
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
METICORTELONE
METI-DERM
Metreton
M-Predrol
NEO-DELTA-CORTEF
Nisolone
Nor-Pred T.B.A.
NSC-9120
NSC-9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
ORAPRED
Panafcortelone
Paracortol
Paracotol
PEDIAPRED
PEVANTI
POLY-PRED
PRDL
Precortalon
Precortancyl
Precortilon
PRECORTISYL
PRECORTISYL FTE
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
PREDL
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone acetate
Prednisolone sodium phosphate
Prednisolone tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
PRELONE
Prenolone
Rolisone
SCHERIPROCT
Scherisolon
SERVISONE
Solone
Steran
STERANE
Sterolone
Supercortisol
TRIDESILON
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
VERDESO
Δ(1)-dehydrocortisol
Δ(1)-dehydrohydrocortisone
Δ(1)-hydrocortisone
Δ-cortef
|
|
18 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 3 |
|
2921-57-5 |
1875 |
Synonyms:
Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinic acid
|
Methylprednisolone hydrogen succinate
Methylprednisolone succinate
|
|
19 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 3 |
|
83-43-2 |
4159 6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6Α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
1-Dehydro-6alpha-methylhydrocortisone
1-Dehydro-6a-methylhydrocortisone
1-Dehydro-6α-methylhydrocortisone
6 Methylprednisolone
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6a-Methylprednisolone
6-Methylprednisolone
6Α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
6Α-methylprednisolone
Artisone-Wyeth
Besonia
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
Dopomedrol
Esametone
Firmacort
J3.872E
Lemod
Medesone
Medixon
Medlone 21
Medrate
Medric acid
Medrol
Medrol Adt Pak
Medrol Dosepak
Medrol®|U-67590A
Medrone
Mesopren
|
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
Nirypan
Noretona
NSC-19987
Predni N Tablinen
Promacortine
Reactenol
Sieropresol
Solomet
SOLU-MEDROL
Summicort
Suprametil
U-67590A
Urbason
Urbasone
Wyacort
Δ(1)-6a-methylhydrocortisone
Δ(1)-6α-methylhydrocortisone
|
|
20 |
|
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium |
Experimental |
Phase 3 |
|
461-06-3 |
|
Synonyms:
CARNITINE
CARNITINE CHLORIDE
|
|
|
21 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 3 |
|
2920-86-7 |
4897 |
Synonyms:
(+)-prednisolone hemisuccinate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethoxy)-4-oxobutanoate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
PREDNISOLONE HEMISUCCINATE
Prednisolone hemisuccinic acid
Prednisolone hydrogen succinate
PREDNISOLONE SUCCINATE
|
|
22 |
|
Antineoplastic Agents, Hormonal |
|
Phase 3 |
|
|
|
23 |
|
Anti-Inflammatory Agents |
|
Phase 3 |
|
|
|
24 |
|
Antimetabolites |
|
Phase 3 |
|
|
|
25 |
|
Insulin, Globin Zinc |
|
Phase 3 |
|
|
|
26 |
|
Insulin |
|
Phase 3 |
|
|
|
Synonyms:
AFREZZA
EXUBERA
HUMULIN
HUMULIN BR
HUMULIN R
HUMULIN R KWIKPEN
HUMULIN R PEN
INS HUMULIN R
INSULIN
INSULIN (HUMAN)
INSULIN BOVINE
INSULIN BOVINE INSULIN
|
INSULIN HUMAN
INSULIN HUMAN (BIOSYNTHESIS)
INSULIN HUMAN (SYNTHESIS)
INSULIN RECOMBINANT HUMAN
INSULIN RECOMBINANT PURIFIED HUMAN
INSUMAN INFUSAT
MYXREDLIN
NOVOLIN
NOVOLIN R
VELOSULIN
VELOSULIN BR
VELOSULIN BR HUMAN
|
|
27 |
|
Epoetin Alfa |
|
Phase 3 |
|
|
|
Synonyms:
BINOCRIT
EPO
EPOETIN ALFA
EPOGEN
|
EPREX
ERYTHROPOIETIN PRECURSOR
PROCRIT
|
|
28 |
|
Anesthetics |
|
Phase 3 |
|
|
|
29 |
|
Anti-Infective Agents, Local |
|
Phase 3 |
|
|
|
30 |
|
Hemostatics |
|
Phase 3 |
|
|
|
31 |
|
Coagulants |
|
Phase 3 |
|
|
|
32 |
|
glucocorticoids |
|
Phase 3 |
|
|
|
33 |
|
Methylprednisolone Acetate |
|
Phase 3 |
|
|
584547 |
Synonyms:
Acetyl methylprednisolone
Acetyl-methylprednisolone
DEPMEDALONE
Depo medrol
Depo medrone
Depo-medrol
Depo-medrone
|
MEDROL ACETATE
Methylprednisolone 21 acetate
METHYLPREDNISOLONE ACETATE
Methylprednisolone acetate, (11beta,16alpha)-isomer
Methylprednisolone acetate, (11beta,16beta)-isomer
Methylprednisolone acetic acid
Methylprednisolone-21-acetate
|
|
34 |
|
Oxytetracycline |
Approved, Investigational, Vet_approved |
Phase 1, Phase 2 |
|
79-57-2 |
54715139 54675779 |
Synonyms:
2058-46-0 (mono-Hydrochloride)
5-Hydroxytetracycline
5-Hydroxy-tetracycline
6153-64-6 (Di-hydrate)
6153-65-7 (Di-hydrochloride salt, di-hydrate)
7179-50-2 (Calcium (1:1) salt)
79-57-2 (ANHYDROUS)
Abbocin
Adamycin
Antibiotic TM 25
Berkmycen
Biostat
Biostat pa
Bisolvomycin
CHEMOCYCLINE
Dabicycline
Dalimycin
E703
EMBRYOSTAT
Fanterrin
GALENOMYCIN
Galsenomycin
Geomycin
Geotilin
HI-TET
Hydroxytetracycline
HYDROXYTETRACYCLINUM
Imperacin
Lenocycline
Liquamycin
Liquamycin la 200
Macocyn
Medamycin
MEPATAR
MICROTET
Mycoshield TMQTHC 20
NSC 9169
NSC-9169
NSC9169 (HCL)
Oksisyklin
Ossitetraciclina
OTC
OTC372
Oxacycline
|
Oxitetraciclina
Oxitetracyclin
OXITETRACYCLINE
Oxitetracyclinum
OXTC
Oxydon
Oxy-kesso-tetra
Oxymycin
Oxymykoin
Oxypam
Oxysteclin
Oxyterracin
Oxyterracine
Oxyterracyne
Oxytetracid
Oxytetracyclin
OXYTETRACYCLINE
OXYTÉTRACYCLINE
Oxytetracycline (anhydrous)
Oxytetracycline amphoteric
Oxytetracycline anhydrous
Oxytetracycline calcium
OXYTETRACYCLINE DIHYDRATE
Oxytetracyclinum
OXYTETRAMIX-250
Pennox 200
Proteroxyna
Riomitsin
Ryomycin
Solkaciclina
Stecsolin
Stevacin
Tarocyn
Tarosin
Teravit
Terrafungine
Terramitsin
Terramycin
Tetran
TETRAPLEX
Unimycin
Ursocyclin
Ursocycline
Vendarcin
|
|
35 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 2 |
|
564-25-0 |
54671203 |
Synonyms:
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
5-Hydroxy-a-6-deoxytetracycline
5-Hydroxy-alpha-6-deoxytetracycline
5-Hydroxy-α-6-deoxytetracycline
6a-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6Α-deoxy-5-oxytetracycline
Anhydrous doxycycline
BMY-28689|Monodox®|Vibramycin®
Doxcycline anhydrous
Doxiciclina
DOXY
Doxychel
Doxycyclin
Doxycycline
|
Doxycycline (anhydrous)
DOXYCYCLINE ANHYDROUS
DOXYCYCLINE HCL
Doxycycline hyclate
Doxycycline hydrate
Doxycycline hydric acid
Doxycycline monohydrate
Doxycycline monohydric acid
Doxycyclinum
Doxytetracycline
GS-3065
Jenacyclin
Monodox
Oracea
Supracyclin
Vibramycin
|
|
36 |
|
Anti-Infective Agents |
|
Phase 2 |
|
|
|
37 |
|
Anti-Bacterial Agents |
|
Phase 2 |
|
|
|
38 |
|
Antiprotozoal Agents |
|
Phase 2 |
|
|
|
39 |
|
Antiparasitic Agents |
|
Phase 2 |
|
|
|
40 |
|
Antimalarials |
|
Phase 2 |
|
|
|
41 |
|
Sorafenib |
Approved, Investigational |
Phase 1 |
|
284461-73-0 |
216239 |
Synonyms:
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate
4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
BAY 43-9006
BAY 43-9006|BAY-439006|Nexavar®
BAY-43-9006
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
|
Nexavar
SORAFENIB
Sorafénib
Sorafenib N oxide
Sorafenib N-oxide
Sorafenib tosylate
Sorafenibum
|
|
42 |
|
Protein Kinase Inhibitors |
|
Phase 1 |
|
|
|
43 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
|
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
44 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
|
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
45 |
|
Parathyroid hormone |
Approved, Investigational |
|
|
9002-64-6 |
|
Synonyms:
ALX1-11
ALX-111
ALX-1-11
NPSP558
NPSP-558
Parathormone
Parathormone (human recombinant)
Parathyrin
PARATHYROID HORMONE
Parathyroid hormone (1-84) human recombinant
|
Parathyroid hormone (rDNA)
PAROIDIN
PREOTACT
PTH
PTH(1-84)
rhPTH
rhPTH(1-84)
rPTH
rPTH(1-84)
|
|
46 |
|
Racepinephrine |
Approved, Vet_approved |
|
|
51-43-4, 329-65-7 |
838 5816 |
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]BENZYL ALCOHOL(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]-BENZYL ALCOHOL
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenaline
(−)-ADRENALINE
(-)-Epinephrine
(+-)-Adrenaline
(+-)-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(−)-ADRENALINE
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
2-(Methylamino)-1-(3,4-dihydroxyphenyl)ethanol
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-HYDROXY-2-METHYLAMINOETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]PYROCATECHOL
Acetate, epinephrine
Adnephrine
ADREN CO
ADRENACLICK
Adrenal
Adrenalin
adrenalin|Auvi-Q®|Epipen®|l-adrenaline|L-epinephrine|levoepinephrine
Adrenaline
Adrénaline
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
adrenaline|epinephrine
Adrenine
Adrin
Allergan brand OF adrenaline hydrochloride
ANA-GUARD
Ana-kit
ANAPEN
ANAPHYLACTIC SHOCK DRUG KIT
ASMA-VYDRIN
ASTHMAHALER
Auvi-Q
Bird brand OF racepinefrine hydrochloride
Bosmin
Bronkaid mist
BROVON
Chelafrin
DL-Adrenaline
EMERADE
EPI E Z PEN JR
Epifrin
Epiglaufrin
Epinefrin
Epinefrina
Epinephran
Epinephrin
EPINEPHRINE
Epinephrine acetate
Epinephrine bitartrate
EPINEPHRINE HCL
Epinephrine hydrochloride
Epinephrine hydrochloride, racemic mixture
Epinephrine hydrogen tartrate
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Epinephrinum
Epipen
|
EPIPEN E Z PEN
Epipen JR
EPIPEN JR.
Epirenan
Epitrate
Eppy
Exadrin
Glauposine
GPPE INH SOLN
Hemisine
Hemostasin
Hemostatin
Hydrochloride, racepinephrine
Hypernephrin
Isoptoepinal
JEXT
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-DETHYLAMINOETHANOLCATECHOL
L-Epinephrine
L-Epirenamine
Levoepinephrine
LEVO-METHYLAMINOETHANOLCATECHOL
Levorenen
Levorenin
Levorenine
Levoreninum
L-Methylaminoethanolcatechol
Lyodrin
Lyophrin
Medihaler-epi
Methylarterenol
Micronefrin
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Mucidrina
Nephridine
Nieraline
NSC-62786
Paranephrin
Primatene
Primatene mist
R-(-)-Epinephrine
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Renaglandin
Renaleptine
Renalina
Renoform
Renostypticin
Renostyptin
RIDDOBRON
RIDDOFAN
RYBARVIN
Scurenaline
Simplene
SOLN MADE TO RYBARVIN FOR
Styptirenal
Supracapsulin
Supranephrane
Suprarenaline
Suprarenin
Surrenine
Sus-phrine
SUS-PHRINE SULFITE FREE
SUS-PHRINE SULFITE-FREE
SYMJEPI
Takamina
TWINJECT
TWINJECT 0.15
TWINJECT 0.3
Vaponefrin
Vasoconstrictine
Vasotonin
|
|
47 |
|
Selenium |
Approved, Investigational, Vet_approved |
|
|
7783-07-5, 7782-49-2 |
533 |
Synonyms:
[SeH2]
Dihydrogen monoselenide
Dihydrogen selenide
H2Se
Hydrogen selenide, 75Se-labeled
Hydroselenate
Hydroselenic acid
Se(2+)
Se2+
Selane
Selanediide
Selen
|
Selenide
Selenide(2-)
Selenio
Sélénium
Selenium dication
Selenium dihydride
Selenium elemental
Selenium hydride
Selenium hydride (seh2)
Selenium ion (se2+)
Selenium metallicum
Selenium, elemental
|
|
48 |
|
Povidone-iodine |
Approved |
|
|
25655-41-8 |
|
Synonyms:
Iodopovidone
Povidone iodine
Povidone, iodinated
|
|
|
49 |
|
Povidone K30 |
Approved, Experimental, Withdrawn |
|
|
9003-39-8 |
6917 131751496 |
Synonyms:
1-Ethenyl-2-pyrrolidinone
1-Ethenyl-2-pyrrolidinone (9ci)
1-Ethenyl-2-pyrrolidinone homopolymer
1-Ethenyl-2-pyrrolidinone homopolymer, 9ci
1-Ethenyl-2-pyrrolidinone polymers
1-Ethenyl-2-pyrrolidinone, homopolymer
1-Vinyl-2-pyrrolidinone
1-Vinyl-2-pyrrolidinone cross-linked insoluble polymer
1-Vinyl-2-pyrrolidinone homopolymer
1-Vinyl-2-pyrrolidinone polymer
1-Vinyl-2-pyrrolidinone, monomer
1-Vinyl-2-pyrrolidinone, polymer
1-Vinyl-2-pyrrolidone
1-Vinyl-2-pyrrolidone polymer
1-Vinylpyrrolidin-2-one
1-vinylpyrrolidin-2-one homopolymer
1-Vinylpyrrolidinone
1-Vinylpyrrolidone
2-Pyrrolidinone, 1-ethenyl, homopolymer
2-Pyrrolidinone, 1-ethenyl-, homopolymer
2-Pyrrolidinone, 1-vinyl-, polymers
Agent at 717
Agent at-717
Agrimer
Albigen a
Aldacol Q
Alphadine
Alphadines
Antaron P 804
Arufil
Betadine
Betadines
Betaisodona
Betaisodonas
Bolinan
Bolinan 40
Crospovidone
Disadine
Disadines
Dulcilarme
Dulcilarmes
Duratears free
Enterode
Enterodes
Enterodez
Ganex P 804
Ganex P-804
Hemodesis
Hemodez
Huntington laboratories brand OF povidone iodine
Huntington laboratories brand OF povidone-iodine
Hypotear
Hypotears
Isodine
Isodines
K 115 (Polyamide)
K 25
K 25 (Polymer)
K 30
K 30 (Polymer)
K 60
K 60 (Polymer)
K115 (Polyamide)
K25 (Polymer)
K30 (Polymer)
K60 (Polymer)
Kollidin CLM
Kollidon
Kollidon 17
Kollidon 25
'Kollidon 25'
Kollidon 30
Kollidon CL
Lacophtal
Lacri-stulln
Lagrifilm
Liquifilm lagrimas
Luviskol
Luviskol K 30
Luviskol K 90
Luviskol K30
Luviskol K-30
Luviskol K90
N- Vinyl pyrrolidone
Neocompensan
Nutrivisc
N-Vinyl pyrrolidone
N-Vinyl-2-pyrrolidinone
N-Vinyl-2-pyrrolidone
N-Vinyl-2-pyrrolidone polymer
N-Vinylbutyrolactam polymer
N-Vinylpyrrolidinone
N-Vinylpyrrolidinone polymer
N-Vinylpyrrolidone
N-Vinylpyrrolidone polymer
N-Vinylpyrrolidone-2
Oculotect
Peragal ST
Peregal ST
Periston
Periston-N
Peviston
Pharmadine
Pharmadines
'plasdone'
Plasdone
Plasdone 4
Plasdone K 29-32
Plasdone K-26/28
Plasdone K29/32
Plasdone K29-32
|
Plasdone no. 4
Plasdone XL
Plasmosan
Polividone
Polvidone
Poly(1-(2-oxo-1-pyrrolidinyl)-1,2-ethanediyl)
Poly(1-(2-oxo-1-pyrrolidinyl)ethylene)
Poly(1-ethenyl-2-pyrrolidinone)
Poly(1-vinyl-2-pyrrolidinone)
Poly(1-vinyl-2-pyrrolidinone) homopolymer
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.1
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.2
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.3
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.4
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.5
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.6
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.7
Poly(1-vinyl-2-pyrrolidone)
Poly(1-vinylpyrrolidinone)
Poly(N-vinyl-2-pyrrolidinone)
Poly(N-vinyl-2-pyrrolidone)
Poly(N-vinylbutyrolactam)
Poly(N-vinylpyrrolidinone)
Poly(N-vinylpyrrolidone)
Poly(vinylpolypyrrolidone)
Poly(vinylpyrrolidinone)
Poly(vinylpyrrolidone)
Polyclar a. t
Polyclar a. t.
Polyclar at
Polyclar H
Polyclar L
Polyclar-at
Polygyl
Poly-N-vinyl pyrrolidone
Poly-N-vinylpyrrolidone
Polyplasdone
Polyplasdone XL
Polyvidon
Polyvidons
Polyvidonum
Polyvinyl pyrrolidone
Polyvinylpolypyrrolidone
Polyvinylpyrrolidone
Polyvinylpyrrolidone iodine
Polyvinylpyrrolidone iodines
Polyvinylpyrrolidone K 30
Polyvinylpyrrolidone K-29/32
Polyvinylpyrrolidone K30
Polyvinylpyrrolidone polymers
Polyvinylpyrrolidone, cross-linked
Povidona
Povidone
Povidone iodine
Povidone K29/32
Povidone K29-32
Povidone(usan)
Povidone, ban, usan
Povidone, unspecified
Povidone-iodine
Povidone-iodines
Povidonum
Protagen
Protagens
Protagent
Providine
Providines
PVP 1
PVP 2
PVP 3
PVP 4
PVP 40
PVP 5
PVP 6
PVP 7
PVP Iodine
PVP K 3
PVP K30
PVP K-30
PVP10_SIAL
PVP40_SIAL
PVP-I
PVP-Iodine
PVP-Iodines
PVP-K 15
PVP-K 3
PVP-K 30
PVP-K 60
PVP-K 90
PVPP
Refresh
Sauflon
Soothe
Subtosan
Tears plus
Tolpovidone I 131
Tolpovidone I-131
Toxobin
Unifluid
Unspecified povidone
Vidirakt S mit PVP
Vidisic PVP ophtiole
Vinisil
Vinyl-2-pyrrolidone
Vinylbutyrolactam
Vinylpyrrolidinone
Vinylpyrrolidinone polymer
Vinylpyrrolidone
Vinylpyrrolidone polymer
V-Pyrol
Wet-comod
|
|
50 |
|
Lutetium Lu 177 dotatate |
Approved, Investigational |
|
|
437608-50-9 |
76966897 |
Synonyms:
(177Lu-dotaotyr3)octreotate
(177Lutetium-dota(O)tyr3)octreotate
(Lu)lutetium(3+) ion 2-[4-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]-C-hydroxycarbonimidoyl}-6,9,12,15,18-pentahydroxy-7-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-16-[(4-oxidophenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-19-yl]-C-hydroxycarbonimidoyl}-2-phenylethyl]carboximidato}methyl)-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic acid
177Lu-DOTA-octreotate
177Lu-dotatATE
177Lu-DOTA-Tyr3-octreotate
Dotatate lutenium Lu-177
DOTATATE-177lu
Lu-177 dotATE
|
Lu-DOTA-TATE
Lutathera
lutenium
Lutetium (177lu) oxodotreotide
Lutetium dotatate Lu-177
lutetium Lu 177 dotatate
Lutetium lu 177 dotatic acid
Lutetium oxodotreotide lu-177
|
|
Interventional clinical trials:
(show top 50)
(show all 78)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Pregnancy |
Unknown status |
NCT01779817 |
Phase 4 |
|
2 |
A Randomized Controlled Clinical Trial on the Effectiveness of Lithium in Comparison to Carbimazole as a Bridging Therapy Prior to Radioactive Iodine for Hyperthyroidism |
Completed |
NCT05512715 |
Phase 4 |
|
3 |
The Influence of Continuous Treatment With Antithyroid Drugs on the Effect of Radioiodine in Patients With Hyperthyroidism |
Completed |
NCT00150137 |
Phase 4 |
Methimazole |
4 |
Short Term Effects of Propanolol on Heart Rate Variability of Hyperthyroidism |
Completed |
NCT03393728 |
Phase 4 |
Propanolol |
5 |
The Influence of Continuous Block-replacement Therapy on the Effect of Radioiodine in Patients With Hyperthyroidism |
Completed |
NCT00150124 |
Phase 4 |
MTZ+LT4;Methimazole |
6 |
Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy |
Completed |
NCT03379181 |
Phase 4 |
Propranolol |
7 |
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease |
Completed |
NCT00946296 |
Phase 4 |
Potassium Iodide |
8 |
Randomized Clinical Trial, Blinded for the Researcher and Multicenter, to Evaluate the Efficacy and Safety of Preoperative Preparation With Lugol Solution in Euthyroid Patients With Graves-Basedow Disease. |
Recruiting |
NCT03980132 |
Phase 4 |
Lugols Strong Iodine |
9 |
A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism |
Unknown status |
NCT03303053 |
Phase 3 |
Cholestyramine Powder 4g;Prednisolone;Standard treatment |
10 |
Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis: Review on the Pathway of Insulin Resistance, Lipid, Inflammation, and Endothelial Dysfunction to Pulse Wave Velocity and Carotid Intima-Media Thickness |
Completed |
NCT05118542 |
Phase 3 |
Propylthiouracil;Methimazole |
11 |
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism: A Clinical Trial With Historical Control |
Completed |
NCT01039818 |
Phase 3 |
|
12 |
Early Administration of L-carnitine in Hemodialysis Patients: Double Blind Randomized Trial Versus Placebo |
Completed |
NCT00322322 |
Phase 3 |
L-Carnitine |
13 |
Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid Nodules |
Recruiting |
NCT05142904 |
Phase 3 |
Radioactive iodine |
14 |
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter |
Recruiting |
NCT04856488 |
Phase 3 |
Iodine-Potassium Iodide 5%-10% Oral and Topical Solution |
15 |
A Phase III, Randomized, Controlled, Open Label, no Profit, Single-center Intervention Study to Compare the Effect of a Conservative (Antithyroid Drugs) and an Ablative Approach (Radioiodine or Total Thyroidectomy) for the Treatment of Hyperthyroidism in Patients With Graves' Disease and Moderate-to-severe and Active Graves' Orbitopathy (GO) Treated With Intravenous Glucocorticoids (ABLAGO Study) |
Not yet recruiting |
NCT04776993 |
Phase 3 |
Methimazole |
16 |
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy: a Prospective, Uncontrolled Pilot Study |
Completed |
NCT01727973 |
Phase 1, Phase 2 |
Doxycycline |
17 |
The Effect of Subantimicrobial Dose Doxycycline in Mild Thyroid-Associated Ophthalmopathy |
Recruiting |
NCT02203682 |
Phase 2 |
Doxycycline hyclate;Placebo |
18 |
An Open-label Study in Healthy Male Subjects to Assess the Effect of Hyperthyroidism Mimicked by Oral Dosing of Levothyroxine on the Pharmacokinetics of Sorafenib |
Completed |
NCT02332031 |
Phase 1 |
Sorafenib (Nexavar, BAY43-9006);Levothyroxine |
19 |
Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma |
Completed |
NCT04346901 |
Phase 1 |
Thiamazol |
20 |
Comparison of Standardized Update Value Using Single-photo Emission Computed Tomography and Computed Tomography Between Grave's Disease (Hyperthyroidism) Patients and Normal Humans |
Unknown status |
NCT02772705 |
|
|
21 |
Subclinical Hyperthyroidism "To Treat or Not to Treat?" A Dutch Multicenter Trial |
Unknown status |
NCT00151723 |
|
|
22 |
GRAves Selenium Supplementation Trial (GRASS) - an Investigator-initiated Randomised, Blinded, Multicentre Clinical Trial of Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism |
Unknown status |
NCT01611896 |
|
|
23 |
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism |
Unknown status |
NCT02812888 |
|
thionamide treatment for 3 months |
24 |
A Parallel, Double-blind, Randomized Controlled Trial for the Evaluation of the Treatment and Outcome of Hyperthyroidism With Iodized Salt and Non Iodized Salt |
Unknown status |
NCT03444246 |
|
|
25 |
Identification and Regulation of Brown Adipose Tissue (BAT) in Humans. Implications for Energy Expenditure in Humans and in the Treatment of Obesity and Related Metabolic Diseases |
Unknown status |
NCT02133040 |
|
|
26 |
Effect of Radioactive Iodine on Eradication of Helicobacter Pylori in Patients Treated for Thyroid Diseases |
Unknown status |
NCT00822289 |
|
|
27 |
Efficacy Of Non Invasive Diagnostic Procedures In Evaluating The Influence Of Maternal Autoimmune Thyroid Gland Disease On Fetus |
Unknown status |
NCT02017080 |
|
|
28 |
Treatment of M.Graves With Radioactive Iodine: Follow-up Study |
Unknown status |
NCT00525122 |
|
|
29 |
Making Accurate Problem Lists in the EHR |
Unknown status |
NCT01105923 |
|
|
30 |
NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation. A Correlation Study |
Unknown status |
NCT01145040 |
|
|
31 |
Study on the Relationship Between the Thyroid Hormones and the Activity of Brown Adipose Tissue in Human |
Unknown status |
NCT01376648 |
|
|
32 |
The Application of Rapid PTH Test Paper in Operation of Hyperparathyroidism |
Unknown status |
NCT03434067 |
|
|
33 |
Localization of Parathyroid Adenoma by Fluorocholine Positron Emission Tomography/MRI (PET/MRI): A Prospective Pilot Study |
Unknown status |
NCT02843542 |
|
|
34 |
Prevention of Iodinated Contrast Media Induced Hyperthyroidism in Patients With Euthyroid Goiter |
Completed |
NCT04304794 |
|
Prophylactic administration of antithyroid drugs before iodinated contrast media exposure |
35 |
Thyroid Disorders in Malaysian: A Nationwide Multicentre Study |
Completed |
NCT02190214 |
|
|
36 |
Efficacy of Thiamine Supplement for Improve Cardiovascular Function in Patients With Severe Hyperthyroidism |
Completed |
NCT02767245 |
|
Thiamine |
37 |
Low Doses of Cholestyramine in the Treatment of Hyperthyroidism |
Completed |
NCT00677469 |
|
Cholestyramine;Placebo powder |
38 |
Randomized Open Clinical Study to Evaluate the Efficacy of Selenium Plus Methimazole for Treatment of Graves' Hyperthyroidism |
Completed |
NCT02727738 |
|
Methimazole |
39 |
Effectiveness of Classical Potassium Iodide Therapy for the Treatment of Untreated Patients With Graves' Hyperthyroidism, Avoiding Thionamide Drugs With Serious Side Effects of Agranulocytosis, Liver Injury, Vasculitis, Embryopathy or Frequent Side Effects of Skin Eruption |
Completed |
NCT04686006 |
|
Potassium Iodide |
40 |
Study of the Efficacy and Safety on the Ultrasonic Ablation Treatment for Secondary Hyperthyroidism in Chronic Kidney Disease Patients. |
Completed |
NCT01640184 |
|
Active vitamin D |
41 |
Postoperative Hyperthyroidism After Parathyroidectomy |
Completed |
NCT01095341 |
|
|
42 |
Morbidity and Mortality Associated With the Care Journey in Children and Adolescents With Hyperthyroidism |
Completed |
NCT03951532 |
|
|
43 |
The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter |
Completed |
NCT01384786 |
|
|
44 |
Observational Prospective Case-control Study on Prevalence and Impact of Subclinical Hyperthyroidism in Patients Undergoing Atrial Fibrillation Ablation |
Completed |
NCT01789541 |
|
|
45 |
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice |
Completed |
NCT02107794 |
|
|
46 |
Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism |
Completed |
NCT02005250 |
|
|
47 |
Quantitative Analysis of 99mTc-Pertechnetate Thyroid Uptake With a Large Field CZT Gamma Camera: Feasibility and Comparison Between SPECT/CT and Planar Acquisitions |
Completed |
NCT05049551 |
|
|
48 |
Metabolomics of Thyroid Hormones |
Completed |
NCT03823859 |
|
|
49 |
Evaluation of the Effectivity of Teleconsultations for Improving the Referrals From Primary Care to Specialized Care of Patients With Chronic Endocrinological Conditions |
Completed |
NCT02710799 |
|
|
50 |
Follow-up Study of Hyperthyroid Patients Treated With RAI in 1965-2002: Morbidity in Long-Term Follow-up |
Completed |
NCT00471458 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Sodium Iodide
|
Sodium iodide I123
|
Cochrane evidence based reviews: hyperthyroidism
|